for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Allogene Therapeutics Reports Q4 Loss Of $0.58 Per Share

Feb 27 (Reuters) - Allogene Therapeutics Inc:

* ALLOGENE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.58

* Q4 EARNINGS PER SHARE ESTIMATE $-0.69 -- REFINITIV IBES DATA

* ALLOGENE THERAPEUTICS- EXPECTS FY 2020 GAAP NET LOSSES TO BE BETWEEN $260 MILLION AND $280 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up